B65.0

Clinical Causes: Contact with contaminated freshwater sources: The primary cause of urinary schistosomiasis is swimming, bathing, or washing in water infested with Schistosoma haematobium larvae. Presence of infected snail hosts: The parasite's lifecycle involves specific freshwater snails that harbor the larval stage. Infection occurs when these larvae penetrate human skin upon water contact. Living in or traveling to endemic regions: People residing or traveling in areas where the parasite is common are at increased risk. Poor sanitation practices: Lack of proper waste disposal can maintain and spread the lifecycle of the parasite in water sources.

Key Symptoms: Hematuria (blood in the urine): A hallmark sign, caused by inflammation and damage to the bladder lining. Frequent urination and dysuria (pain or discomfort during urination) Lower abdominal pain Increased urinary frequency or urgency Nocturia (waking at night to urinate) Itching or irritation in the genital area In some cases, presence of blood clots in urine Long-term complications may include bladder wall thickening, fibrosis, or increased risk of bladder cancer

Diagnosis Path: Diagnosis typically involves a combination of medical history, exposure history, and laboratory testing. Tests may include microscopic examination of urine samples to identify parasite eggs, or more advanced diagnostics like urine filtration techniques and serology tests. Imaging studies such as ultrasound can be used to assess bladder and urinary tract damage. In some instances, tissue biopsies may be necessary to evaluate extent of tissue involvement.

Treatment Protocols: The primary treatment for urinary schistosomiasis is antiparasitic medication. Praziquantel is the most effective drug, usually given in a single dose or as prescribed by a healthcare instruction. Managing symptoms like hematuria may require additional supportive care. Preventive measures include avoiding contact with contaminated water, using protective clothing, and improving sanitation practices to reduce transmission. Long-term follow-up may be necessary to monitor and manage potential complications such as bladder fibrosis or increased cancer risk.